Literature DB >> 9435199

Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells.

T Lindmark1, Y Kimura, P Artursson.   

Abstract

Medium chain fatty acids (MCFAs) are used to enhance the permeability of mucosal tissues to hydrophilic drugs, but their mechanism of action is largely unknown. In this study, the absorption-enhancing effects of the sodium salts of two MCFAs, capric acid (C10) and lauric acid (C12), were studied in monolayers of human intestinal epithelial Caco-2 cells. Both MCFAs induced a rapid increase in epithelial permeability to the hydrophilic marker molecule sodium fluorescein. Inhibition of phospholipase C and inhibition or activation of various kinases and buffering of intracellular calcium indicated that the effects on epithelial permeability were mediated through phospholipase C-dependent inositol triphosphate/diacylglycerol pathways. Surprisingly, the inositol triphosphate and diacylglycerol pathways were found to have opposing effects on paracellular permeability. Exposure to the MCFAs also resulted in a concentration dependent reduction of cellular dehydrogenase activity and ATP levels. C10, but not C12, induced redistribution of the tight junction proteins ZO-1 and occludin. These results indicate that the two MCFAs have partially different and more complex mechanisms than previously recognized, which has important implications for their use in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9435199

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  52 in total

1.  Fatty acids and epithelial permeability: effect of conjugated linoleic acid in Caco-2 cells.

Authors:  H M Roche; A M Terres; I B Black; M J Gibney; D Kelleher
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 2.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

3.  Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models.

Authors:  Wei Zhou; Liu-qing Di; Juan Wang; Jin-jun Shan; Shi-jia Liu; Wen-zheng Ju; Bao-chang Cai
Journal:  Acta Pharmacol Sin       Date:  2012-07-09       Impact factor: 6.150

Review 4.  Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin.

Authors:  Haiqi Chen; Dolores D Mruk; Weiliang Xia; Michele Bonanomi; Bruno Silvestrini; Chuen-Yan Cheng
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

5.  Safe and effective permeation enhancers for oral drug delivery.

Authors:  Kathryn Whitehead; Natalie Karr; Samir Mitragotri
Journal:  Pharm Res       Date:  2007-12-05       Impact factor: 4.200

Review 6.  Critical role of tight junctions in drug delivery across epithelial and endothelial cell layers.

Authors:  L González-Mariscal; P Nava; S Hernández
Journal:  J Membr Biol       Date:  2005-09       Impact factor: 1.843

7.  Mechanistic analysis of chemical permeation enhancers for oral drug delivery.

Authors:  Kathryn Whitehead; Samir Mitragotri
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

Review 8.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

9.  A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug.

Authors:  Mohammed M Alvi; Parnali Chatterjee
Journal:  AAPS PharmSciTech       Date:  2013-12-20       Impact factor: 3.246

10.  Alterations of intercellular junctions in peritoneal mesothelial cells from patients undergoing dialysis: effect of retinoic Acid.

Authors:  Carmen Retana; Elsa Sanchez; Alejandro Perez-Lopez; Armando Cruz; Jesus Lagunas; Carmen Cruz; Socorro Vital; Jose L Reyes
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.